moclobemide has been researched along with Hypermyotonia in 1 studies
Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.
Excerpt | Relevance | Reference |
---|---|---|
"We report a case of severe serotonin syndrome after self-poisoning with two antidepressant drugs, paroxetine (a selective inhibitor of serotonin reuptake) and moclobemide (a reversible inhibitor of MAO-A)." | 3.69 | [Serotonin syndrome in acute poisoning with antidepressive agents]. ( Cabot, C; Cathala, B; Fabre, M; Robert, P; Senard, JM, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Robert, P | 1 |
Senard, JM | 1 |
Fabre, M | 1 |
Cabot, C | 1 |
Cathala, B | 1 |
1 other study available for moclobemide and Hypermyotonia
Article | Year |
---|---|
[Serotonin syndrome in acute poisoning with antidepressive agents].
Topics: Adult; Antidepressive Agents; Benzamides; Humans; Male; Moclobemide; Muscle Hypertonia; Paroxetine; | 1996 |